Hikma Pharmaceuticals: Pain trials
The registry lists 11 Pain studies with Hikma Pharmaceuticals as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 5Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric SubjectsCompletedNCT01322360Phase 4Results posted
- A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural PainTerminatedNCT01676493Phase 3
- Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted ConditionsCompletedNCT01210638Phase 1
- Comparative Bioavailability Study of Codeine SulfateCompletedNCT01010152Phase 1
- Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted ConditionsCompletedNCT01010139Not applicable
- Food Effect Study of Codeine SulfateCompletedNCT01009892Phase 1
- Steady State Study of Codeine SulfateCompletedNCT01009853Phase 1
- Dose Linearity Study of Codeine Sulfate Under Fasted ConditionsCompletedNCT01009697Phase 1
- Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted ConditionsCompletedNCT00994942Not applicable
- Dose Proportionality and Food Effect of Morphine SulfateCompletedNCT00994539Not applicable
- Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled ReleaseCompletedNCT00994383Not applicable